Danielle Brill
Stock Analyst at Truist Securities
(3.7)
Main Sectors:
30 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PVLA Palvella Therapeutic... | Maintains: Strong Buy | 56 80 | 64.39 | 24.24% | 2 | Oct 2, 2025 | |
VRTX Vertex Pharmaceutica... | Initiates Coverage On: Market Perform | n/a | n/a | n/a | 3 | Sep 3, 2025 | |
IRON Disc Medicine | Initiates Coverage On: Buy | 86 | 66.82 | 28.7% | 6 | Jul 21, 2025 | |
ALNY Alnylam Pharmaceutic... | Initiates Coverage On: Buy | 385 | 455.02 | -15.39% | 1 | Jul 21, 2025 | |
HRMY Harmony Biosciences ... | Initiates Coverage On: Buy | 48 | 27.07 | 77.32% | 8 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 64 | 15.12 | 323.28% | 2 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 163 | 136.1 | 19.76% | 6 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 66 | 52.32 | 26.15% | 1 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 23.28 | 28.87% | 1 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 18.21 | 31.8% | 1 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Strong Buy | 20 52 | 56.01 | -7.16% | 6 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 79 | 55.19 | 43.14% | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 18 | 10.75 | 67.44% | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 36 | 16.88 | 113.27% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 150 | 22.05 | 580.27% | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Strong Buy | 605 | 795.14 | -23.91% | 7 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 5 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 50 | 39.76 | 25.75% | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 51 | 40.75 | 25.15% | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 180 100 | 8.08 | 1137.62% | 5 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 9 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Oct 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 75 50 | n/a | n/a | 5 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Aug 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Aug 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Sep 17, 2019 |